Format

Send to

Choose Destination
Blood. 2016 Jun 16;127(24):3094-8. doi: 10.1182/blood-2016-04-709899. Epub 2016 May 3.

CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML.

Author information

1
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;
2
Children's Oncology Group, Monrovia, CA;
3
Nemours Center for Cancer and Blood Disorders, Alfred I. duPont Hospital for Children, Wilmington, DE;
4
Office of Cancer Genomics, National Cancer Institute, Bethesda, MD;
5
Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada;
6
Arkansas Children's Hospital Research Institute and Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR;
7
Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD;
8
Children's Oncology Group, Monrovia, CA; Division of Hematology/Oncology/Bone Marrow Transplantation, Children's Mercy Hospitals and Clinics, Kansas City, MO; and.
9
Children's Oncology Group, Monrovia, CA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA.
10
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Children's Oncology Group, Monrovia, CA;
PMID:
27143256
PMCID:
PMC4911865
DOI:
10.1182/blood-2016-04-709899
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center